Feed Preview

Fast Growing

Fetal Erythroblastosis

Fetal Erythroblastosis diagram by #N/A

Fetal erythroblastosis or hemolytic disease of the newborn is a type of anemia in which fetal red blood cells are destroyed as a result of maternal immune reaction caused by blood group incompatibility. Here is the latest research.

Top 20 most recent papers
Circulation Research

MicroRNA-145 Regulates the Differentiation of Adipose Stem Cells Toward Microvascular Endothelial Cells and Promotes Angiogenesis

Circulation ResearchJune 21, 2019
Gemma ArderiuLina Badimon
The Journal of Physiology

Gestational intermittent hypoxia induces endothelial dysfunction, reduces perivascular adiponectin and causes epigenetic changes in adult male offspring

The Journal of PhysiologyAugust 24, 2019
Mohammad BadranIsmail Laher
Clinical Chemistry

Amplicon Sequencing-Based Noninvasive Fetal Genotyping for RHD -Positive D Antigen-Negative Alleles

Clinical ChemistrySeptember 7, 2019
Ken TakahashiKenichiro Hata
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis

A case report on anti-Mia antibody in a multi-transfused patient from India

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for HaemapheresisSeptember 5, 2019
Soma Agrawal, Mohit Chowdhry
Transfusion Medicine Reviews

Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jra : A Case Study and Review of the Literature

Transfusion Medicine ReviewsApril 26, 2019
Shinji KatsuragiTomoaki Ikeda
NeuroImage. Clinical

Advanced MRI analysis to detect white matter brain injury in growth restricted newborn lambs

NeuroImage. ClinicalAugust 23, 2019
Atul MalhotraSuzanne Lee Miller
Transfusion Medicine

A novel silent RHCE allele in Chinese population

Transfusion MedicineAugust 19, 2019
Fang-Hui ZhaoZ Y Zhu
Cancer Research and Treatment : Official Journal of Korean Cancer Association

Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray

Cancer Research and Treatment : Official Journal of Korean Cancer AssociationJune 19, 2019
Sung Kook KimHo Kyung Seo

Acute hemolytic transfusion reaction associated with anti-Mta : case report and review of the literature

TransfusionSeptember 11, 2019
Vincent ClaesHanane El Kenz
Journal of Reproductive Immunology

The two-stage placental model of preeclampsia: An update

Journal of Reproductive ImmunologyJuly 14, 2019
Anne Cathrine Annetine Staff
BMC Nephrology

Reduced membrane attack complex formation in umbilical cord blood during Eculizumab treatment of the mother: a case report

BMC NephrologyAugust 7, 2019
Subagini NagarajahClaus Bistrup
Asian Journal of Andrology

Prevalence and clinical application of TMPRSS2-ERG fusion in Asian prostate cancer patients: a large-sample study in Chinese people and a systematic review

Asian Journal of AndrologyJune 14, 2019
De-Pei KongYing-Hao Sun

Single Nucleotide Polymorphisms of NUCB2 and their Genetic Associations with Milk Production Traits in Dairy Cows

GenesJune 13, 2019
Bo HanDong-Xiao Sun
Molecular Carcinogenesis

Aberrant ERG expression associates with downregulation of miR-4638-5p and selected genomic alterations in a subset of diffuse large B-cell lymphoma

Molecular CarcinogenesisJune 24, 2019
Shanxiang ZhangLiang Cheng

Conquering erythroblastosis fetalis: 50 years of RhIG

TransfusionJuly 1, 2019
Sarah R Vossoughi, Steven L Spitalnik

Cold reacting anti-M causing delayed hemolytic disease of the newborn

TransfusionOctober 31, 2019
Philip J CrispinFarah Sethna
BMC Pregnancy and Childbirth

Management of acutely decompensated chronic thromboembolic pulmonary hypertension in late pregnancy: a case report

BMC Pregnancy and ChildbirthOctober 21, 2019
Luca ValkóJanos Gal
Molecular Pharmacology

Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines

Molecular PharmacologySeptember 27, 2019
Trista K HinzLynn E Heasley
The Journal of Physiology

First evidence that intrinsic fetal heart rate variability exists and is affected by hypoxic pregnancy

The Journal of PhysiologyDecember 4, 2019
Martin G. FraschDino A. Giussani

Complications in pregnant women with sickle cell disease

HematologyDecember 6, 2019
Kim Smith-Whitley

See more papers from this feed

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2019 Meta ULC. All rights reserved